Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JIN-A02 |
Trade Name | |
Synonyms | JIN A02|JINA02 |
Drug Descriptions |
JIN-A02 is a fourth-generation EGFR inhibitor that targets EGFR mutations including C797S, which potentially results in decreased tumor growth (Ann Oncol 2022, Vol 33, Supp 7:S1010-S1011). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | C188241 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JIN-A02 | JIN-A02 | 0 | 1 |